IHS Chemical Week

People & Business :: M&A

Pfizer's animal health unit Zoetis sets terms for $2-billion IPO

12:34 PM MST | January 23, 2013 | Natasha Alperowicz

Zoetis, the Pfizer animal health medicines and vaccines unit, on Thursday announced terms for its previously reported initial public offering of shares (IPO). The company plans to raise about $2.2 billion by offering 86.1 million shares at a price range of $22.00 to $25.00. At the midpoint of the proposed range, Zoetis would command a fully diluted market value of $11.8 billion. Zoetis, which was founded in 2012 and reported $4.3 billion in sales for the 12 months ended 30 September 2012, plans to list on the New York Stock Exchange under the symbol ZTS. J.P...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa